ZAP-X Gyroscopic Radiosurgery Platform to Debut in Taiwan at Kaohsiung Show Chwan Memorial Hospital

KAOHSIUNG CITY, Taiwan--(BUSINESS WIRE)--ZAP Surgical Systems, Inc., a global leader in non-invasive robotic brain surgery, today announced that the first vault-free ZAP-X® Gyroscopic Radiosurgery® platform in Taiwan will be installed at Kaohsiung Show Chwan Memorial Hospital (KSCH). This marks a significant milestone in the region’s adoption of cutting-edge stereotactic radiosurgery (SRS) technology. Installation is set to begin in Q4 2025, with patient treatments expected to commence in Q1 2026.

KSCH, a newly opened medical facility, is the latest addition to the Show Chwan Healthcare System, one of Taiwan’s leading medical networks. With the introduction of ZAP-X, KSCH aims to further elevate its existing Neuro-Oncology practice, offering advanced, non-invasive treatment options for patients with primary and metastatic brain tumors, as well as other neurological disorders.

Stereotactic radiosurgery (SRS) is a completely non-invasive and painless procedure that has emerged as a game-changer in the treatment of brain tumors and other disorders of the brain, head, and neck. Unlike conventional open surgery, SRS requires no incision, and treatments typically require just a single brief outpatient visit. It is not uncommon for patients to return to normal activities the same day as treatment.

“SRS is revolutionizing the way we treat brain tumors and neurological conditions,” said Dr. Min-Ho Huang, President of Show Chwan Healthcare System. “With the addition of ZAP-X at KSCH, we are reinforcing our commitment to providing world-class, non-invasive treatment solutions to patients in Taiwan and beyond.”

The adoption of ZAP-X at KSCH represents a significant step forward in Taiwan’s neuro-oncology landscape. The system eliminates the need for costly shielded radiation treatment rooms, making advanced radiosurgery more accessible. Additionally, unlike historical systems that rely on Cobalt-60 radioactive sources, ZAP-X utilizes a modern linear accelerator for radiation generation, reducing the logistical and financial burdens of handling and regularly replacing radioactive isotopes.

The ZAP-X system is distinguished by its unique gyroscopic maneuverability, enabling the delivery of radiosurgical beams from thousands of potential angles to precisely target tumors while minimizing radiation exposure to critical structures such as the brain stem, eyes, and optic nerves. This innovative approach also enhances patient safety and preserves cognitive function by reducing radiation exposure to healthy brain tissue.

Show Chwan Healthcare System has historically treated SRS patients with Cobalt-60-based delivery technology. The addition of ZAP-X provides a next-generation alternative that aims to enhance treatment versatility and precision.

For details on ZAP-X and its technology, visit www.zapsurgical.com.

About ZAP Surgical Systems, Inc.

ZAP Surgical Systems, Inc. designs and manufactures the ZAP-X® Gyroscopic Radiosurgery® platform. ZAP was founded in 2014 by Dr. John R. Adler, Emeritus Dorothy & TK Chan Professor of Neurosurgery and Radiation Oncology at Stanford University. Dr. Adler is also renowned as the inventor of the CyberKnife^® system and founder of Accuray, Inc. The ZAP-X platform incorporates a unique vault-free design that typically eliminates the need for costly shielded treatment rooms. ZAP-X also utilizes a modern linear accelerator to eliminate legacy use of Cobalt-60. Learn more at ZAP Surgical and follow us on LinkedIn.